12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bedaquiline regulatory update

FDA's Anti-Infective Drugs Advisory Committee will meet on Nov. 28 to discuss an NDA from Johnson & Johnson's Janssen Research & Development LLC unit for bedaquiline to treat multi-drug-resistant...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >